SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-18-001553
Filing Date
2018-03-06
Accepted
2018-03-06 16:02:21
Documents
70
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 10-K glyc-20171231x10k.htm 10-K 2472174
2 EX-23.1 glyc-20171231ex23108a6d3.htm EX-23.1 9661
3 EX-31.1 glyc-20171231ex311180936.htm EX-31.1 13064
4 EX-31.2 glyc-20171231ex3129485ea.htm EX-31.2 13237
5 EX-32.1 glyc-20171231ex321d9524c.htm EX-32.1 11172
6 GRAPHIC glyc20171231x10k001.jpg GRAPHIC 68099
7 GRAPHIC glyc20171231x10k002.jpg GRAPHIC 76194
8 GRAPHIC glyc20171231x10k003.jpg GRAPHIC 86095
  Complete submission text file 0001558370-18-001553.txt   7453088

Data Files

Seq Description Document Type Size
9 EX-101.INS glyc-20171231.xml EX-101.INS 1381967
10 EX-101.SCH glyc-20171231.xsd EX-101.SCH 40938
11 EX-101.CAL glyc-20171231_cal.xml EX-101.CAL 40495
12 EX-101.DEF glyc-20171231_def.xml EX-101.DEF 173326
13 EX-101.LAB glyc-20171231_lab.xml EX-101.LAB 357340
14 EX-101.PRE glyc-20171231_pre.xml EX-101.PRE 308398
Mailing Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-243-1201
GLYCOMIMETICS INC (Filer) CIK: 0001253689 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36177 | Film No.: 18669859
SIC: 2834 Pharmaceutical Preparations